Horizon's Revised TED Indication Should Help Tepezza

Good News For Amgen, But Viridian Looms As Competition

 
• By Joseph Haas
  
eye disease
Revised indication for Tepezza should mean broader patient access within TED • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D